Collaborate Disseminate
A new study published in Nature Communications has added to the growing body of evidence reporting similarities between long COVID and chronic fatigue syndrome (ME/CFS). The research found around half of the long COVID patients studied fit the diagnost… Continue reading New evidence affirms link between long COVID and chronic fatigue syndrome
A huge new study has offered the most robust investigation to date into the symptoms and prevalence of long COVID in non-hospitalized patients. The research identified a diverse set of symptoms associated with long COVID, including reduced libido and h… Continue reading Massive study links long COVID to hair loss and reduced libido
Human trials have shown that hydrogel injections are a promising, effective treatment for chronic lower back pain caused by degenerative disc disease (DDD). The treatment is far less invasive than other surgeries, and has been given FDA approval.Contin… Continue reading Injectable hydrogel treats back pain from damaged discs in human trials
A new study has presented the most rigorous investigation to date into the long-term cognitive impacts of severe COVID-19. The research, led by scientists from Imperial College London and the University of Cambridge, found persistent cognitive deficits… Continue reading Cognitive impact of severe COVID equal to 20 years of brain aging
New research published in The Lancet Respiratory Medicine has followed the recovery of more than 2,000 hospitalized COVID-19 patients. The findings show barely one in four patients reported feeling fully recovered from COVID-19 a year after being disch… Continue reading Most hospitalized COVID patients still recovering a year after discharge
Researchers at the University of Pennsylvania have discovered a new type of cell in the human lung. Named respiratory airway secretory cells (RASCs), they seem to play a role in regenerating other cells and could be a target for new treatments for cert… Continue reading Newly discovered type of lung cell could open door to new COPD treatments
New research from the Massachusetts General Hospital (MGH) and the National Institutes of Health hypothesizes nerve damage as the cause of long COVID symptoms in some people. The small study found treating patients with immunotherapies targeting the ne… Continue reading New studies point to nerve damage as a cause of long COVID
A rapid research review conducted by the UK Health Security Agency (UKHSA) has affirmed prior findings indicating vaccination reduces a person’s risk of developing long COVID. The report also found vaccination after developing long COVID can improve pe… Continue reading UK review affirms vaccination reduces risk of long COVID
A pair of new studies have homed in on key biomarkers that could help identify, at the point of initial infection, those most at risk of developing long COVID. The studies suggest a combination of immune biomarkers and acute symptoms can be used to pre… Continue reading How to predict who is most likely to develop long COVID
A comprehensive new study published in the journal Nature Immunology has reported immune dysregulation persists in long COVID patients up to eight months after initial infection. The Australian research found long COVID is characterized by elevated lev… Continue reading Long COVID patients show abnormal immune activity 8 months post infection